ArticleEndocrinology, diabetes & metabolism case reports2026
Osteoporosis associated with pregnancy and lactation (PLO): can REMS have a role in prevention and follow-up?
Article in Endocrinology, diabetes & metabolism case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
summaryOsteoporosis associated with pregnancy and lactation (PLO) is a debilitating premenopausal osteoporosis that occurs during the last trimester of pregnancy or breastfeeding. Its pathogenesis is complex and remains unclear, and there are currently no established guidelines. Case reports are valuable for clinicians in diagnosis, management, and treatment. We report a case of a young woman with multiple vertebral fractures who received a diagnosis of PLO. The patient was treated with vitamin D, teriparatide, and lifestyle modifications. We monitored the patient's bone mineral density using radiofrequency echographic multi-spectrometry (REMS) technology, a novel ultrasound tool for bone status evaluation. The ability to follow up young patients at risk of PLO using this safe, non-ionizing radiation tool could represent a significant advancement in the management of this condition. LEARNING POINTS:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.